Učitavanje...
Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review
OBJECTIVE: A central adrenergic hyperactivation is described in the neurobiology of posttraumatic stress disorder (PTSD) with probable variable symptomatic impact. Few studies have evaluated using the alpha-1 adrenergic antagonist prazosin for such symptoms; however, given the likely pathophysiology...
Spremljeno u:
| Izdano u: | Psychiatry Investig |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Neuropsychiatric Association
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8169333/ https://ncbi.nlm.nih.gov/pubmed/33979949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30773/pi.2020.0411 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|